What’s Dr. Drew’s net worth?
Celebrity net worth estimates Dr. Drew to be worth $20 Million.
He makes money from all of his television gigs, but he’s also the voice for lap band company 1-800-GET-THIN, and like many celebrities and people with large Twitter followers, he receives money for tweeting.
Recent unearthed documents prove Dr. Drew also received fees to endorse a medication.
This practice is more common that people realize among even regular doctors who don’t have a national soapbox.
Dr. Drew’s pharmaceutical scandals
He still hosts the show Sun-Thur. 10p.m.-12a.m. with cohosts Mike and Simone, but he’s recently been figured in a pharmaceutical scandal dating back to 1999.
Documents from the Justice Department show that Dr. Drew was paid $275,000 by the drug company [GlaxoSmithKline (GSK)] for Wellbutrin SR in exchange for Dr. Drew to “deliver messages about [Wellbutrin SR] in settings where it did not appear that Dr. Pinsky was speaking for GSK.”
One of those messages?
Apparently on Loveline Dr. Drew said that Wellbutrin can increase a woman’s orgasm rate to possibly 60 a night!
After that broadcast, according to the Justice Department’s report, GSK sent around a memo about how Dr. Drew had “communicated key campaign messages.”
Now, keep in mind that Dr. Drew has not been charged with a crime, and he told Forbes that “My comments were consistent with my clinical experience.”
See also: Dr. Drew And GlaxoSmithKline Comment On Past Antidepressant Promotion
Jul 3, 2012 @ 08:12 PM
Last night, I wrote about how Dr. Drew Pinsky, famous as host of the radio show LoveLine and host of his own show on CNN’s HLN network, was a paid spokesperson for a Glaxo Wellcome awareness campaign in 1999, according to documents released as part of a settlement between the Department of Justice and GlaxoSmithKline.
The government alleges that Pinsky was paid a total of $275,000 over just two months – March and April 1999 – to deliver messages about Wellbutrin SR, a Glaxo antidepressant, “in settings where it did not appear that Dr. Pinsky was speaking for GSK.”
This evening, both Pinsky and GlaxoSmithKline have responded to the questions I asked them yesterday. Pinsky, through an emailed comment sent via a spokeswoman, writes:
In the late 90s I was hired to participate in a 2 year initiative discussing intimacy and depression which was funded by an educational grant by Glaxo Wellcome. Services for the non branded campaign included town hall meetings, writings and multi media activities in conjunction with the patient advocacy group the National Depressive and Manic Depressive Association (NDMDA). My comments were consistent with my clinical experience.
The spokeswoman also sent along an archived version of the website associates with the campaign.
A Glaxo spokeswoman wrote:
The complaint does not reflect what would be allowed in GSK today. We continually evolve and improve our business practices to align to the expectations of society and government and to our values of transparency, integrity, respect and focus on the patient. We have increased our controls to require disclosure of financial relationships of HCPs and the company. We voluntarily have posted those on our website for the past few years.
See also: https://www.forbes.com/sites/matthewherper/2012/07/02/feds-say-dr-drew-was-paid-by-glaxo-to-talk-up-antidepressant/#18c78dbc51ec